The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S1801: A randomized trial of adjuvant versus neoadjuvant pembrolizumab for melanoma.
 
Sapna Pradyuman Patel
Honoraria - Merck
Consulting or Advisory Role - Cardinal Health; TriSalus Life Sciences
Research Funding - Bristol-Myers Squibb (Inst); Deciphera (Inst); Foghorn Therapeutics (Inst); InxMed (Inst); Novartis (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - Cardinal Health; Clinica Santa Maria; Merck
Other Relationship - Immunocore
 
Megan Othus
Consulting or Advisory Role - Cascadia Labs; Celgene; Daiichi Sankyo; Glycomimetics; Merck
Other Relationship - Celgene; Glycomimetics
 
James Moon
No Relationships to Disclose
 
Michael Tetzlaff
Honoraria - Merck; Myriad Genetics; NanoString Technologies; Novartis
Consulting or Advisory Role - Merck; Myriad Genetics; NanoString Technologies; Novartis
Travel, Accommodations, Expenses - Myriad Genetics; NanoString Technologies
 
Elizabeth Iannotti Buchbinder
Employment - Alexion Pharmaceuticals (I)
Consulting or Advisory Role - Apexigen; Bristol-Myers Squibb; Novartis; Shionogi
Research Funding - Bristol-Myers Squibb; Checkmate Pharmaceuticals; Genentech/Roche; Lilly; Novartis
 
Vernon K. Sondak
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck/Schering Plough; Novartis; Regeneron; Replimune
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Polynoma; Replimune
 
Michael C. Lowe
Research Funding - Bristol-Myers Squibb; Delcath Systems (Inst); Vaccinex (Inst)
 
Catrina Mireles
No Relationships to Disclose
 
Elad Sharon
No Relationships to Disclose
 
Larissa A. Korde
No Relationships to Disclose
 
Samantha Guild
No Relationships to Disclose
 
William Edgar Carson
No Relationships to Disclose
 
Antoni Ribas
Leadership - Arcus Biosciences; Lutris; PACT Pharma
Stock and Other Ownership Interests - 4c Biomed; Advaxis; Arcus Biosciences; Compugen; CytomX Therapeutics; Five Prime Therapeutics; Highlight Therapeutics; ImaginAb; Isoplexis; Kite/Gilead; Lutris; MapKure; Merus; PACT Pharma; RAPT Therapeutics; Rgenix; Tango Therapeutics
Honoraria - Amgen; AstraZeneca; Chugai/Roche; Genentech/Roche; Merck Sharp & Dohme; Novartis; Sanofi; Vedanta Biosciences
Consulting or Advisory Role - Amgen; Chugai Pharma; Merck; Novartis; Sanofi
Research Funding - Agilent (Inst); Bristol-Myers Squibb (Inst)
 
Kenneth F. Grossmann
Consulting or Advisory Role - Array BioPharma; Bristo-Meyers Squibb; Natera; Novartis